| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.58▼ | 1.58▼ | 1.58▼ | 1.54▲ | 1.89▼ |
| MA10 | 1.57▼ | 1.55▲ | 1.55▲ | 1.66▼ | 1.95▼ |
| MA20 | 1.58▼ | 1.60▼ | 1.61▼ | 1.84▼ | 1.89▼ |
| MA50 | 1.69▼ | 1.77▼ | 1.77▼ | 1.92▼ | 1.87▼ |
| MA100 | 1.79▼ | 1.89▼ | 1.90▼ | 1.87▼ | 2.01▼ |
| MA200 | 1.93▼ | 1.94▼ | 1.92▼ | 1.89▼ | 1.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | 0.011▲ | 0.009▲ | -0.041▼ | -0.039▼ |
| RSI | 44.502▼ | 43.424▼ | 42.876▼ | 38.840▼ | 41.610▼ |
| STOCH | 58.475 | 62.857 | 51.701 | 14.361▼ | 40.386 |
| WILL %R | -48.571 | -63.265 | -63.265 | -82.353▼ | -83.019▼ |
| CCI | 11.218 | -18.716 | -19.407 | -74.875 | -179.024▼ |
|
Thursday, August 07, 2025 05:00 PM
BeyondSpring Inc. Annual cash flow by MarketWatch. View BYSI net cash flow, operating cash flow, operating expenses and cash dividends.
|
|
Monday, July 07, 2025 04:13 AM
BeyondSpring Inc. has announced promising results from a clinical study published in Med, showing that Plinabulin, when combined with radiation and PD-1 inhibitors, elicited a 23% overall response ...
|
|
Tuesday, June 03, 2025 04:12 AM
BeyondSpring presents Phase 2 data showing Plinabulin's potential in metastatic NSCLC after PD-1/L1 therapy, with promising survival rates. BeyondSpring Inc. announced promising interim results from ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/01/26 | 1.58 | 1.605 | 1.56 | 1.56 | 34,859 |
| 07/01/26 | 1.46 | 1.6596 | 1.38 | 1.53 | 99,816 |
| 06/01/26 | 1.54 | 1.54 | 1.45 | 1.50 | 62,232 |
| 05/01/26 | 1.6035 | 1.675 | 1.50 | 1.51 | 84,219 |
| 02/01/26 | 1.66 | 1.74 | 1.53 | 1.61 | 86,564 |
| 31/12/25 | 1.70 | 1.72 | 1.60 | 1.63 | 165,581 |
| 30/12/25 | 1.78 | 1.78 | 1.71 | 1.71 | 96,494 |
| 29/12/25 | 1.80 | 1.84 | 1.77 | 1.82 | 59,929 |
| 26/12/25 | 1.87 | 1.91 | 1.81 | 1.84 | 69,570 |
| 24/12/25 | 1.86 | 1.92 | 1.8311 | 1.92 | 16,270 |
|
|
||||
|
|
||||
|
|